Pharming Group (OTCMKTS:PHGUF) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.47 and traded as high as $1.50. Pharming Group shares last traded at $1.47, with a volume of 6,608 shares trading hands.
Separately, Zacks Investment Research raised Pharming Group from a “sell” rating to a “hold” rating in a report on Wednesday, January 6th.
The firm has a market capitalization of $920.04 million, a PE ratio of 21.00 and a beta of 1.65. The company has a debt-to-equity ratio of 1.00, a quick ratio of 4.08 and a current ratio of 4.45. The business’s fifty day simple moving average is $1.47 and its 200-day simple moving average is $1.28.
Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema in Europe, the United States, Israel, and South Korea.
Read More: What is a closed-end mutual fund (CEF)?
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.